Alector (ALEC) Other Non Operating Income (2018 - 2026)
Alector's (ALEC) quarterly Other Non Operating Income came in at $1.5 million in Q2 2026, down 57.58% year-over-year from $3.6 million in Q2 2025, and down 22.93% quarter-over-quarter from $2.0 million in Q1 2026.
Analysis
Alector (ALEC) Other Non Operating Income (2018 - 2026) Analysis & Trends
Alector (ALEC) has reported Other Non Operating Income for 9 consecutive years, with $1.5 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Other Non Operating Income fell 57.58% year-over-year to $1.5 million in Q2 2026; TTM through Jun 2026 was $8.9 million, a 53.67% decrease from a year earlier, with the FY2025 full-year figure at $13.2 million, down 49.2% from the prior year.
- Other Non Operating Income was $1.5 million for Q2 2026 at Alector, down from $2.0 million in the prior quarter.
- Over five years, Other Non Operating Income peaked at $11.1 million in Q4 2022 and troughed at $264000.0 in Q1 2022.
- A 5-year average of $4.7 million and a median of $4.7 million in 2023 frame the typical range for Other Non Operating Income.
- Across the five-year window, Other Non Operating Income jumped 1854.17% in 2023 and tumbled 57.58% in 2026, its largest moves.
- Over 5 years, Other Non Operating Income stood at $11.1 million in 2022, then sank by 30.36% to $7.7 million in 2023, then plunged by 32.38% to $5.2 million in 2024, then slumped by 52.77% to $2.5 million in 2025, then slumped by 37.86% to $1.5 million in 2026.
- The last three Other Non Operating Income figures came in at $1.5 million (Q2 2026), $2.0 million (Q1 2026), and $2.5 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn |
| 10 | Alector | 274.68 Mn | 101.88 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.53 Mn |
| Mar 31, 2026 | 1.99 Mn |
| Dec 31, 2025 | 2.47 Mn |
| Sep 30, 2025 | 2.94 Mn |
| Jun 30, 2025 | 3.61 Mn |
| Mar 31, 2025 | 4.22 Mn |
| Dec 31, 2024 | 5.22 Mn |
| Sep 30, 2024 | 6.21 Mn |
| Jun 30, 2024 | 7.00 Mn |
| Mar 31, 2024 | 7.64 Mn |
| Dec 31, 2023 | 7.72 Mn |
| Sep 30, 2023 | 7.36 Mn |
| Jun 30, 2023 | 6.36 Mn |
| Mar 31, 2023 | 5.16 Mn |
| Dec 31, 2022 | 11.09 Mn |
| Sep 30, 2022 | 2.33 Mn |
| Jun 30, 2022 | 1.45 Mn |
| Mar 31, 2022 | 264,000.00 |
| Dec 31, 2021 | 6.13 Mn |
| Sep 30, 2021 | 268,000.00 |